This study aimed to assess pharmacy students’ knowledge about doping substances used in sport, explore their attitudes toward doping and investigate their misuse of doping drugs. A questionnaire was developed and employed to collect data from bachelor of pharmacy (BPharm) students at the International University for Science and Technology (IUST). Two-hundred and eighty students participated in this self-administrated, paper-based survey. Around 90% of the students did not appear to know that narcotics, β-blockers and diuretics were used in sport as doping agents. Additionally, proportions between 60% and 80% considered vitamins, energy drinks and amino acids as substances that possess performance-enhancing effects. The main reason for doping, based on students’ response, was to improve muscular body appearance. The vast majority of students agreed that pharmacists should play a major role in promoting awareness about risks of doping. While students showed negative attitudes toward doping, approximately 15% of them, primarily males, had already tried a doping drug or might do so in the future. More than 60% of the students believed that sports-mates and friends are the most influential in encouraging them to take a doping agent. The study highlights the need to provide pharmacy students with advanced theoretical background and practical training concerning doping. This can be achieved by adopting simple, but essential, changes to the current curricula.
References
[1]
Holt, R.I.; Erotokritou-Mulligan, I.; Sonksen, P.H. The history of doping and growth hormone abuse in sport. Growth Horm IGF Res. 2009, 19, 320–326, doi:10.1016/j.ghir.2009.04.009.
[2]
Westerbeek, H.; Smith, A. Sport Business in the Global Marketplace; Palgrave Macmillan: New York, NY, USA, 2003; pp. 1–51.
[3]
Bloodworth, A.J.; Petroczi, A.; Bailey, R.; Pearce, G.; McNamee, M.J. Doping and supplementation: The attitudes of talented young athletes. Scand. J. Med. Sci Sports 2012, 22, 293–301, doi:10.1111/j.1600-0838.2010.01239.x.
[4]
Kindlundh, A.M.; Isacson, D.G.; Berglund, L.; Nyberg, F. Doping among high school students in Uppsala, Sweden: A presentation of the attitudes, distribution, side effects, and extent of use. Scand. J. Soc. Med. 1998, 26, 71–74.
[5]
Yesalis, C.E.; Bahrke, M.S. Doping among adolescent athletes. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 2000, 14, 25–35, doi:10.1053/beem.2000.0051.
[6]
Kartakoullis, N.L.; Phellas, C.; Pouloukas, S.; Petrou, M.; Loizou, C. The use of anabolic steroids and other prohibited substances by Gym enthusiasts in Cyprus. Int. Rev. Sociol. Sport 2008, 43, 271–287, doi:10.1177/1012690208098545.
[7]
Baker, J.S.; Graham, M.R.; Davies, B. Steroid and prescription medicine abuse in the health and fitness community: A regional study. Eur. J. Intern. Med. 2006, 17, 479–484, doi:10.1016/j.ejim.2006.04.010.
[8]
Mallia, L.; Lucidi, F.; Zelli, A.; Violani, C. Doping attitudes and the use of legal and illegal performance-enhancing substances among Italian adolescents. J. Child. Adolesc. Subst. Abuse 2013, 22, 179–190, doi:10.1080/1067828X.2012.733579.
[9]
Papadopoulos, F.C.; Skalkidis, I.; Parkkari, J.; Petridou, E. Doping use among tertiary education students in six developed countries. Eur. J. Epidemiol. 2006, 21, 307–313, doi:10.1007/s10654-006-0018-6.
[10]
Striegel, H.; Simon, P.; Frisch, S.; Roecker, K.; Dietz, K.; Dickhuth, H.H.; Ulrich, R. Anabolic ergogenic substance users in fitness-sports: A distinct group supported by the health care system. Drug Alcohol. Depend. 2006, 81, 11–19, doi:10.1016/j.drugalcdep.2005.05.013.
[11]
Tokish, J.M.; Kocher, M.S.; Hawkins, R.J. Ergogenic aids: A review of basic science, performance, side effects, and status in sports. Am. J. Sports Med. 2004, 32, 1543–1553, doi:10.1177/0363546504268041.
[12]
Sjoqvist, F.; Garle, M.; Rane, A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet 2008, 371, 1872–1882, doi:10.1016/S0140-6736(08)60801-6.
[13]
Saugy, M.; Robinson, N.; Saudan, C.; Baume, N.; Avois, L.; Mangin, P. Human growth hormone doping in sport. Br. J. Sports Med. 2006, 40 (Suppl 1), i35–i39, doi:10.1136/bjsm.2006.027573.
[14]
Kanayama, G.; Gruber, A.J.; Pope, H.G., Jr.; Borowiecki, J.J.; Hudson, J.I. Over-the-counter drug use in gymnasiums: An underrecognized substance abuse problem? Psychother. Psychosom. 2001, 70, 137–140, doi:10.1159/000056238.
[15]
World Anti-Doping Agency The 2013 Prohibited List. Available online: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2013/WADA-Prohibited-List-2013-EN.pdf (accessed on 25 May 2013).
[16]
Nikolopoulos, D.D.; Spiliopoulou, C.; Theocharis, S.E. Doping and musculoskeletal system: Short-term and long-lasting effects of doping agents. Fundam. Clin. Pharmacol. 2011, 25, 535–563, doi:10.1111/j.1472-8206.2010.00881.x.
[17]
Nemet, D.; Eliakim, A. protein and amino acid supplementation in sport. Int. Sport Med. J. 2007, 8, 11–23.
[18]
Seifert, S.M.; Schaechter, J.L.; Hershorin, E.R.; Lipshultz, S.E. Health effects of energy drinks on children, adolescents, and young adults. Pediatrics 2011, 127, 511–528, doi:10.1542/peds.2009-3592.
[19]
Smith, A.C.; Stewart, B. Drug policy in sport: Hidden assumptions and inherent contradictions. Drug Alcohol. Rev. 2008, 27, 123–129, doi:10.1080/09595230701829355.
[20]
Furlanello, F.; Serdoz, L.V.; Cappato, R.; De Ambroggi, L. Illicit drugs and cardiac arrhythmias in athletes. Eur J. Cardiovasc. Prev. Rehabil. 2007, 14, 487–494, doi:10.1097/HJR.0b013e3280ecfe3e.
[21]
Bohn, A.M.; Khodaee, M.; Schwenk, T.L. Ephedrine and other stimulants as ergogenic aids. Curr. Sports Med. Rep. 2003, 2, 220–225, doi:10.1249/00149619-200308000-00009.
[22]
Catlin, D.H.; Fitch, K.D.; Ljungqvist, A. Medicine and science in the fight against doping in sport. J. Intern. Med. 2008, 264, 99–114, doi:10.1111/j.1365-2796.2008.01993.x.
[23]
Kennedy, M.C.; Lawrence, C. Anabolic steroid abuse and cardiac death. Med. J. Aust. 1993, 158, 346–348.
[24]
Hausmann, R.; Hammer, S.; Betz, P. Performance enhancing drugs (doping agents) and sudden death--a case report and review of the literature. Int J. Legal Med. 1998, 111, 261–264, doi:10.1007/s004140050165.
[25]
Laure, P.; Kriebitzsch-Lejeune, A. Retail pharmacists and doping in sports: Knowledge and attitudes. A national survey in France. Sci Sports 2000, 15, 141–146, doi:10.1016/S0765-1597(00)80018-0.
[26]
Auersperger, I.; Topic, M.D.; Maver, P.; Pusnik, V.K.; Osredkar, J.; Lainscak, M. Doping awareness, views, and experience: A comparison between general practitioners and pharmacists. Wien. Klin. Wochenschr. 2012, 124, 32–38, doi:10.1007/s00508-011-0077-x.
[27]
Saito, Y.; Kasashi, K.; Yoshiyama, Y.; Fukushima, N.; Kawagishi, T.; Yamada, T.; Iseki, K. Survey on the attitudes of pharmacy students in Japan toward doping and supplement intake. Biol. Pharm. Bull. 2013, 36, 305–310, doi:10.1248/bpb.b12-00315.
[28]
Ambrose, P.J. An advanced pharmacy practice experience in sports pharmacy. Am. J. Pharm. Educ. 2008, 72, doi:10.5688/aj720119.
[29]
Ambrose, P.J. Educational opportunities and anti-doping roles and responsibilities for pharmacists. Yakugaku Zasshi 2011, 131, 1761–1764, doi:10.1248/yakushi.131.1761.
[30]
Deaner, R.O.; Geary, D.C.; Puts, D.A.; Ham, S.A.; Kruger, J.; Fles, E.; Winegard, B.; Grandis, T. A sex difference in the predisposition for physical competition: Males play sports much more than females even in the contemporary US. PLoS One 2012, 7, e49168.
[31]
Petroczi, A.; Aidman, E.V.; Nepusz, T. Capturing doping attitudes by self-report declarations and implicit assessment: A methodology study. Subst. Abuse Treat. Prev. Policy 2008, 3, 9, doi:10.1186/1747-597X-3-9.
[32]
El-Hammadi, M. Syrian pharmacy students’ intentions and attitudes toward postgraduate education. Am. J. Pharm. Educ. 2012, 76, 147, doi:10.5688/ajpe768147.
[33]
El-Hammadi, M. Career preferences of Syrian students and their attitudes toward a number of practice areas: Will community pharmacy continue to dominate the profession? Curr. Pharm. Teach. Learn. 2013, 5, 373–380, doi:10.1016/j.cptl.2013.03.004.
